Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Facteur antihémophilique A")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2435

  • Page / 98
Export

Selection :

  • and

Electroblotting of factor VIII/ Von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontimuous buffer systemBATLLE, J; LOPEZ-FERNANDEZ, M. F; LOPEZ BERGES, C et al.British journal of haematology. 1983, Vol 55, Num 1, pp 195-196, issn 0007-1048Article

Von Willebrand factor: a protein which binds at the cell surface interface between plateletsSENOGLES, S. E; NELSESTUEN, G. L.The Journal of biological chemistry (Print). 1983, Vol 258, Num 20, pp 12327-12333, issn 0021-9258Article

Factor VIII-related antigen in occluded human arteries anf graftsPOTTER, E. V; GREEN, D; SRIRATANA, P et al.Surgery. 1984, Vol 95, Num 6, pp 683-688, issn 0039-6060Article

Laboratory evaluation of factor VIII and factor IXBAGLINI, R. L.The American journal of medical technology. 1983, Vol 49, Num 12, pp 857-862, issn 0002-9335Article

Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assaysHORNSEY, V; WATERSTON, Y. G; PROWSE, C. V et al.Journal of clinical pathology. 1988, Vol 41, Num 5, pp 562-567, issn 0021-9746Article

The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVPBROMMER, E. J. P; DERKX, F. H. M; BARRETT-BERGSHOEFF, M. M et al.Thrombosis and haemostasis. 1984, Vol 51, Num 1, pp 42-44, issn 0340-6245Article

Von willebrand factor/factor VIII adsorption to surfaces from human plasmaHORBETT, T. A; COUNTS, R. B.Thrombosis research. 1984, Vol 36, Num 6, pp 599-608, issn 0049-3848Article

Factor VIII concentrate: a comparison of manufacturers assays and users assays: report of a survey carried out on behalf of the ICTH subcommittee on Factor VIII activitiesRIZZA, C. R.Thrombosis and haemostasis. 1983, Vol 50, Num 3, pp 753-754, issn 0340-6245Article

Investigation including VIIIR: AG multimeric analysis of a large kindred with type IIA von Willebrand's disease showing a dominant inheritance and similar gene expression in four generationsHILL, F. G. H; ENAYAT, M. S; GEORGE, A. J et al.Thrombosis and haemostasis. 1983, Vol 50, Num 3, pp 735-739, issn 0340-6245Article

Studies on the stability of VIII-C during the manufacture of a factor VIII concentrate for clinical useFOSTER, P. R; DICKSON, I. H; MCQUILLAN, T. A et al.Vox sanguinis (Basel. 1956). 1988, Vol 55, Num 2, pp 81-89, issn 0042-9007Article

A new variant of dominant type II von Willebrands disease with aberrant multimeric pattern of factor VIII-related antigen (type IID)KINOSHITA, S; HARRISON, J; LAZERSON, J et al.Blood. 1984, Vol 63, Num 6, pp 1369-1371, issn 0006-4971Article

Immunological alterations in haemophiliacs treated with lyophilized factor VIII cryoprecipitate from volunteer donorsCEUPPENS, J. L; VERMYLEN, J; COLAERT, J et al.Thrombosis and haemostasis. 1984, Vol 51, Num 2, pp 207-211, issn 0340-6245Article

Dissociation of factor VIII procoagulant antigen VIII: CAg and factor VIII related antigen VIIIR: Ag by EDTA-influence of divalent cation on the binding of VIII: CAg and VIIIR: AgTRAN, T. H; DUCKERT, F.Thrombosis and haemostasis. 1983, Vol 50, Num 2, pp 547-551, issn 0340-6245Article

Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's diseaseCASTELLA, A; MILLER, J. L; NEUBERG, R. W et al.American journal of clinical pathology. 1983, Vol 80, Num 5, pp 745-749, issn 0002-9173Article

Factor assay (VIII and IX) results in the College of American Pathologists survey program (1980-1982)CHRISTENSEN, R. L; TRIPLETT, D. A.American journal of clinical pathology. 1983, Vol 80, Num 4, pp 633-642, issn 0002-9173Article

Heterogeneity of autoantibodies to factor VIII: differences in specificity for appently distinct antigenic determinants of factor VIII coagulant proteinCROISSANT, M.-P; ZUZEL, M; ALLAIN, J.-P et al.Blood. 1983, Vol 62, Num 1, pp 133-140, issn 0006-4971Article

Immunoadsorption of factor VIII inhibitorsFREEDMAN, John; GARVEY, M. Bernadette.Current opinion in hematology. 2004, Vol 11, Num 5, pp 327-333, issn 1065-6251, 7 p.Article

Zur Abhängigkeit der Faktor-VIII-Aktivität von der Blutgruppe = Dépendance du facteur VIII par rapport aux groupes sanguins = On the dependance of the factor-VIII activity upon the blood groupUTEG, K.-H; TAUSENDFREUND, K.Pharmazie. 1985, Vol 40, Num 1, pp 57-58, issn 0031-7144Article

Improved buffer for the chromatographic separation of factor VIII coagulantFAURE, A; CARON, M; TEPENIER, D et al.Journal of chromatography. 1983, Vol 257, Num 2, pp 387-391, issn 0021-9673Article

Dosage du facteur VIII cofacteur de la ristocétine (facteur Willebrand) à ĺaide dun test sur lame semi-quantitatif: résultats préliminairesBOGATY-YVER, J; MUSITELLI, J.-J; CONARD, J et al.Annales de biologie clinique (Paris). 1983, Vol 41, Num 5, pp 319-324, issn 0003-3898Article

THROMBIN POTENTIATION OF FACTOR VIII PROCOAGULANT ACTIVITY: ASSESSMENT BY THE TWO-STAGE ASSAYKOPITSKI RG; SWITZER MEP; MCKEE PA et al.1982; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1982; VOL. 2; NO 47; PP. 145-149; BIBL. 26 REF.Article

INFLUENCE OF TWO DIFFERENT BETA-ADRENERGIC BLOCKING AGENTS ON THE INCREASE IN FIBRINOLYTIC ACTIVITY AND FACTOR VIII ACTIVITY DURING SUBMAXIMUM AND MAXIMUM EXERCISE = INFLUENCE DE 2AGENTS DE BLOCAGE BETA -ADRENERGIQUE DIFFERENTS SUR L'AUGMENTATION DE L'ACTIVITE FIBRINOLYTIQUE ET DE L'ACTIVITE DU FACTEURVIII AU COURS D'UN EXERCICE SUBMAXIMAL ET MAXIMALKORSAN BENGTSEN K; CONRADSON TB.1974; SCAND. J. HAEMATOL.; DENM.; DA. 1974; VOL. 13; NO 5; PP. 377-384; BIBL. 1PArticle

SEPARATION OF HUMAN ANTIHEMOPHILIC FACTOR (AHF, FACTOR VIII) FROM FIBRINOGEN BY MEANS OF DEFIBRASE.LOPACIUK S; LATALLO ZS; BYKOWSKA K et al.1975; FOLIA HAEMATOL.; ALLEM.; DA. 1975; VOL. 102; NO 6; PP. 671-678; ABS. ALLEM. FR. RUSSE; BIBL. 1 P. 1/2Article

Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg)DIETRICH, G; ALGIMAN, M; SULTAN, Y et al.Blood. 1992, Vol 79, Num 11, pp 2946-2951, issn 0006-4971Article

Pharmacokinetic properties of recombinant factor VOOO compared with a monoclonally purified concentrate (Hemofil®M)MORFINI, M; LONGO, G; MESSORI, A et al.Thrombosis and haemostasis. 1992, Vol 68, Num 4, pp 433-435, issn 0340-6245Article

  • Page / 98